Mediplantex National Pharmaceutical Joint Stock Company reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was VND 116,231.99 million compared to VND 67,171 million a year ago. Net income was VND 4,194.7 million compared to net loss of VND 2,961.58 million a year ago. Basic earnings per share from continuing operations was VND 446.
For the full year, revenue was VND 401,051.15 million compared to VND 343,917.02 million a year ago. Net income was VND 6,365.73 million compared to VND 3,619.51 million a year ago. Basic earnings per share from continuing operations was VND 678 compared to VND 1,048 a year ago.